Reply: K-Ras: a prognostic factor for survival in non-small cell lung cancer

被引:0
|
作者
C Mascaux
机构
[1] Institut Jules Bordet Departement de Medecine Interne et Laboratoire d'Investigation Clinique et d'Oncologie Experimentale HJ Tagnon Rue Heger-Bordet 1,
来源
British Journal of Cancer | 2006年 / 94卷
关键词
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:1549 / 1549
相关论文
共 50 条
  • [41] Tissue factor expression in non-small cell lung cancer:: Relationship with vascular endothelial growth factor expression, microvascular density, and K-ras mutation
    Regina, Sandra
    Rollin, Jerome
    Blechet, Claire
    Iochmann, Sophie
    Reverdiau, Pascale
    Gruel, Yves
    JOURNAL OF THORACIC ONCOLOGY, 2008, 3 (07) : 689 - 697
  • [42] Sorafenib in pretreated patients with advanced non-small lung cancer harbouring a K-ras mutation
    Dingemans, Anne-Marie C.
    van Wijk, Atie
    Hochstenbag, Monique
    Thunnissen, Erik
    Meulemans, Els
    Smit, Egbert F.
    JOURNAL OF THORACIC ONCOLOGY, 2009, 4 (09) : S414 - S415
  • [43] The K-ras gene regulates vascular endothelial growth factor gene expression in non-small cell lung cancers
    Konishi, T
    Huang, CL
    Adachi, M
    Taki, T
    Inufusa, H
    Kodama, K
    Kohno, N
    Miyake, M
    INTERNATIONAL JOURNAL OF ONCOLOGY, 2000, 16 (03) : 501 - 511
  • [44] Molecular Biology and Therapeutic Perspectives for K-Ras Mutant Non-Small Cell Lung Cancers
    Cekani, Elona
    Epistolio, Samantha
    Dazio, Giulia
    Cefali, Marco
    Wannesson, Luciano
    Frattini, Milo
    Froesch, Patrizia
    CANCERS, 2022, 14 (17)
  • [45] Hypermetabolism is an independent prognostic factor of survival in metastatic non-small cell lung cancer patients
    Jouinot, Anne
    Ulmann, Guillaume
    Vazeille, Clara
    Durand, Jean-Philippe
    Boudou-Rouquette, Pascaline
    Arrondeau, Jennifer
    Tlemsani, Camille
    Fournel, Ludovic
    Alifano, Marco
    Wislez, Marie
    Chapron, Jeanne
    Le Bris, Camille
    Mansuet-Lupo, Audrey
    Damotte, Diane
    Neveux, Nathalie
    De Bandt, Jean-Pascal
    Alexandre, Jerome
    Cynober, Luc
    Goldwasser, Francois
    CLINICAL NUTRITION, 2020, 39 (06) : 1893 - 1899
  • [46] ALI Could Be a One of Prognostic Survival Factor for Non-Small Cell Lung Cancer Patients
    Hamamoto, Y.
    JOURNAL OF THORACIC ONCOLOGY, 2018, 13 (10) : S996 - S997
  • [47] Development of a Survival Prognostic Model for Non-small Cell Lung Cancer
    Zhang, Yue-Hua
    Lu, Yuquan
    Lu, Hong
    Zhou, Yue-Min
    FRONTIERS IN ONCOLOGY, 2020, 10
  • [48] Survival analysis and prognostic factors in non-small cell lung cancer
    Martin, C
    Bozcuk, H
    BRITISH JOURNAL OF CANCER, 2001, 85 : 58 - 58
  • [49] SBRT Dose and Survival in Non-Small Cell Lung Cancer Reply
    Koshy, Matthew
    Sher, David J.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2015, 92 (04): : 946 - 947
  • [50] Clinical significance and the correlation of expression between Let-7 and K-ras in non-small cell lung cancer
    Xia, Xiao-Ming
    Jin, Wei-Yun
    Shi, Ren-Zhong
    Zhang, Ya-Feng
    Chen, Jun
    ONCOLOGY LETTERS, 2010, 1 (06) : 1045 - 1047